Participants were randomized to receive a single dose of either one of three lots of CAPVAXIVE or PPSV23 (pneumococcal 23-valent polysaccharide ... 13-valent conjugate vaccine], or cohort 3 ...

polysaccharide-based jab Pneumovax 23. Sanofi's new challenger is billed as a "next-generation" pneumococcal conjugate vaccine that, according to the company, is the first candidate with more than ...

The 15-valent conjugate vaccine ... Merck already sells an older pneumococcal vaccine called Pneumovax 23, which protects against 23 strains but is a polysaccharide based shot, so doesn't ...

Expanded recommendations from the Advisory Committee on Immunization Practices on the use of pneumococcal conjugate vaccines may improve ... PCV20 or PCV21 over 23-valent pneumococcal polysaccharide ...

Babies treated with antibiotics in the first few weeks of their life are likely to show weaker immune responses to essential ...

The Knox County Health Department has terminated seven employees ‒ including part of its vaccination team ‒ after the Trump administration cut grants that paid their salaries without warning, Knox ...

pneumococcal conjugate; pneumococcal polysaccharide; polio; rotavirus; RSV; shingles; and tetanus, diphtheria and pertussis. The county's vaccine program distribution will continue, Parton said ...

produced much lower levels of antibodies against multiple polysaccharides included in the 13-valent pneumococcal conjugate vaccine or PCV13 vaccine. Streptococcus pneumoniae, a bacteria known for ...

“Our results, which add to the findings of several important previous studies, indicate that immune responses to certain types of vaccine, particularly protein-polysaccharide conjugate vaccines ...

Merck, known as MSD outside of the United States and Canada, announced that the European Commission (EC) has approved Capvaxive (Pneumococcal 21-valent Conjugate Vaccine) for active immunization for ...